Physician profile
Mitchell V Brock
NPI 1568488435
$2,641.59
in general payments reported to CMS, 2019-2025
30 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $261 · 2021: $432 · 2022: $460 · 2023: $596 · 2024: $290 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001 · Education: $46.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.08 |
| Education | $46.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $473.54 | 2019-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $454.25 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Bayer Healthcare Pharmaceuticals INC. | $326.12 | 2019-2025 | |
| Pfizer INC. | $289.05 | 2019-2024 | |
| Therapeuticsmd, INC. | $157.71 | 2019-2022 | |
| Myriad Women'S Health, INC. | $133.30 | 2023 | Myrisk |
| Coloplast Corp | $109.23 | 2019-2022 | |
| Hologic Sales and Service, LLC | $91.88 | 2022-2025 | Novasure, Aptima |
| Mayne Pharma Commercial LLC | $74.07 | 2024-2025 | |
| Organon LLC | $59.74 | 2021-2024 | |
| Allergan, INC. | $42.68 | 2019-2020 | |
| Conmed Corporation | $40.84 | 2024 | Airseal |
| Evofem Biosciences, INC. | $40.04 | 2020-2022 | |
| Roche Diagnostics Corporation | $37.87 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $32.22 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $29.40 | 2025 | Myfembree |
| Coopersurgical, INC. | $28.41 | 2022-2025 | Sos |
| Merck Sharp & Dohme LLC | $27.66 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $20.13 | 2021 | |
| Duchesnay USA Incorporated | $19.35 | 2019 | |
| Alydia Health | $19.22 | 2021 | |
| Scynexis, INC. | $18.66 | 2022 | |
| Boston Scientific Corporation | $17.85 | 2024 | Advantage System |
| Medtronic, INC. | $17.82 | 2025 | Closurefast |
| Lsi Solutions INC | $17.60 | 2024 | Fornisee |
| Convatec INC. | $15.07 | 2025 | |
| Millicent US INC | $14.34 | 2019 | |
| Avion Pharmaceuticals | $12.22 | 2020 | |
| Amgen INC. | $11.13 | 2021 | |
| Aspira Women'S Health INC | $10.19 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Brock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.